Zum Hauptinhalt springen

tyrosine aminotransferase

Der TAT gene provides instructions for making a liver enzyme called tyrosine aminotransferase. This enzyme is the first in a series of five enzymes that work to break down the amino acid tyrosine, a protein building block found in many foods. Specifically, tyrosine aminotransferase converts tyrosine into a byproduct called 4-hydroxyphenylpyruvate. Continuing the process, 4-hydroxyphenylpyruvate is further broken down and ultimately smaller molecules are produced that are either excreted by the kidneys or used to produce energy or make other substances in the body.

Videoauswahl für Gene
Videothek

Normal function

Der TAT gene provides instructions for making a liver enzyme called tyrosine aminotransferase. This enzyme is the first in a series of five enzymes that work to break down the amino acid tyrosine, a protein building block found in many foods. Specifically, tyrosine aminotransferase converts tyrosine into a byproduct called 4-hydroxyphenylpyruvate. Continuing the process, 4-hydroxyphenylpyruvate is further broken down and ultimately smaller molecules are produced that are either excreted by the kidneys or used to produce energy or make other substances in the body.

Conditions referring to this gene or chromosome

Other names

ATTY_HUMAN

L-tyrosine:2-oxoglutarate aminotransferase

tyrosine transaminase

Related patient information and medicines

Mastozytose und Mastzellenerkrankungen

Patient information leaflet

Mastozytose und Mastzellenerkrankungen

If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on the immune system (such as interferon), bone marrow transplant or... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new.

Chronische myeloische Leukämie

Patient information leaflet

Chronische myeloische Leukämie

Treatment for the initial chronic phase The aim of treatment is to control the disease process, to ease any symptoms and to prevent (or delay) the progress... You may be advised to have one or more of the following treatments: Imatinib tablets. This medicine is known as a tyrosine kinase inhibitor. The chemical tyrosine kinase is made by the.

Mundkrebs

Patient information leaflet

Mundkrebs

Dia... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that ein person should receive a diagnosis or ruling out of cancer within 28 days von being referred urgently by their GP for suspected cancer. To confirm the diagnosis It is likely that you will need a biopsy. Cetuximab is an.

Lapatinib-Tabletten

Medicine leaflet

Lapatinib-Tabletten

Lapatinib is given for the treatment of breast cancer. About lapatinib Type of medicine A tyrosine kinase inhibitor chemotherapy medicine Used for Treatment of breast cancer Also called Tyverb® Available as Tablets Lapatinib is a medicine which is given for the treatment of breast cancer Breast cancer which has progressed despite other treatment,.

Nilotinib-Kapseln

Medicine leaflet

Nilotinib-Kapseln

It is important that you keep the regular appointments with your doct... About nilotinib Type of medicine A tyrosine kinase inhibitor chemotherapy medicine Used for Treatment of chronic myeloid leukaemia Also called Tasigna® Available as Capsules Nilotinib is a medicine which is given to treat leukaemia Leukaemia. Leukaemia is cancer of cells in.

Erlotinib-Tabletten

Medicine leaflet

Erlotinib-Tabletten

Erlotinib is given for the treatment of lung cancer, or for the treatment of cancer of Arztpraxis pancreas. Contact your doctor straightaway if you de... About erlotinib Type of medicine A tyrosine kinase inhibitor chemotherapy medicine Used for Lung cancer, and cancer of the pancreas Also called Tarceva® Available as Tablets Erlotinib is a medicine.

Artikelverlauf

Die Informationen auf dieser Seite werden von qualifizierten Klinikern verfasst und begutachtet.
  • 18. Aug 2020 | Neueste Version
  • 1 Jan 2008 | Ursprünglich veröffentlicht

Nehmen Sie an der Diskussion teil

Teilen Sie Ihre Gedanken oder Erfahrungen mit anderen in unserem Patientengemeinschaften.

Haftungsausschluss: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online-Apotheke, Behandlungen und Gesundheitsdienstleistungen

Einfacher Zugang zu vertrauenswürdigen Behandlungen und Gesundheitsdiensten online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Abonnieren Sie den Patienten-Newsletter

Ihre wöchentliche Dosis klarer, vertrauenswürdiger Gesundheitsberatung - geschrieben, um Ihnen zu helfen, sich informiert, selbstbewusst und in Kontrolle zu fühlen.

Bitte geben Sie eine gültige E-Mail-Adresse ein

Durch das Abonnieren akzeptieren Sie unsere Datenschutzrichtlinie. Sie können sich jederzeit abmelden. Wir verkaufen Ihre Daten niemals.